HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma

被引:12
作者
Wu, Yu [1 ]
Yang, Ye [1 ]
Xian, Yin-Sheng [2 ]
机构
[1] Shaanxi Peoples Hosp, Dept Thorac Surg, Xian 710068, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Oncosurg, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China
关键词
HCRP1; Proliferation; Invasion; Chemosensitivity; Esophageal squamous cell carcinoma (ESCC); SIGNALING PATHWAY; HEPATOCELLULAR-CARCINOMA; MESENCHYMAL TRANSITION; POOR-PROGNOSIS; UP-REGULATION; CANCER; RNA; EMT; EXPRESSION; RESISTANCE;
D O I
10.1016/j.cbi.2019.05.032
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hepatocellular carcinoma related protein 1 (HCRP1), which is essential for internalization and degradation of ubiquitinated membrane receptors, was reported to play crucial roles in cancer pathogenesis and progression. However, the functional roles of HCRP1 in esophageal squamous cell carcinoma (ESCC) remain unknown. In this study, we investigated the effects of HCRP1 on ESCC cells and the underlying mechanism. Our results demonstrated that HCRP1 was lowly expressed in ESCC tissues and cell lines. Overexpression of HCRP1 significantly suppressed ESCC cell proliferation and invasion as well as the epithelial-mesenchymal transition (EMT) process. Furthermore, HCRP1 increased the sensitivity of ESCC cells towards cisplatin/fluorouracil. Mechanistically, HCRP1 inhibited the activity of Wnt/beta-catenin signaling pathway in ESCC cells. In conclusion, these findings indicated that HCRP1 suppressed ESCC cell proliferation and invasion through regulation of the Wnt/beta-catenin pathway. Therefore, HCRP1 may function as a tumor suppressor in ESCC progression.
引用
收藏
页码:357 / 363
页数:7
相关论文
共 48 条
[1]   WNT signalling pathways as therapeutic targets in cancer [J].
Anastas, Jamie N. ;
Moon, Randall T. .
NATURE REVIEWS CANCER, 2013, 13 (01) :11-26
[2]   The growth-regulatory protein HCRP1/hVps37A is a subunit of mammalian ESCRT-I and mediates receptor down-regulation [J].
Bache, KG ;
Slagsvold, T ;
Cabezas, A ;
Rosendal, KR ;
Raiborg, C ;
Stenmark, H .
MOLECULAR BIOLOGY OF THE CELL, 2004, 15 (09) :4337-4346
[3]  
Birchmeier C, 1996, ACTA ANAT, V156, P217
[4]  
Brown, 2000, Ann Epidemiol, V10, P468, DOI 10.1016/S1047-2797(00)00097-1
[5]   Esophageal squamous cell carcinoma (ESCC): advance in genomics and molecular genetics [J].
Chen, J. ;
Kwong, D. L. ;
Cao, T. ;
Hu, Q. ;
Zhang, L. ;
Ming, X. ;
Chen, J. ;
Fu, L. ;
Guan, X. .
DISEASES OF THE ESOPHAGUS, 2015, 28 (01) :84-89
[6]   Cisplatin: From DNA damage to cancer chemotherapy [J].
Cohen, SM ;
Lippard, SJ .
PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 67, 2001, 67 :93-130
[7]   Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial-mesenchymal transition [J].
Cui, Fei ;
Wu, Duoguang ;
He, Xiaotian ;
Wang, Wenjian ;
Xi, Jingle ;
Wang, Minghui .
TUMOR BIOLOGY, 2016, 37 (08) :10871-10876
[8]  
Du Y, 2016, LATE IMP CHINA, V37, P1
[9]   Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process [J].
Gao, Hongli ;
Hao, Guijun ;
Sun, Yue ;
Li, Liye ;
Wang, Yukun .
ONCOTARGETS AND THERAPY, 2018, 11 :8001-8012
[10]  
Gu K, 2015, AM J CANCER RES, V5, P1169